ADVL1322: A Phase II Study of Pazopanib (GW786034, NSC# 737754) in Children, Adolescents and Young Adults with Refractory SolidTumors.

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/152/27/19

Funding

  • Children's Hospital of Philadelphia
  • Novartis Pharmaceuticals Corporation